Home › Disorders of Excessive Somnolence › Missouri › St. Louis
Disorders of Excessive Somnolence clinical trials in St. Louis, MO
3 studies for Disorders of Excessive Somnolence are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
RecruitingPhase 3
- Alkermes Investigational Site, St Louis
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
RecruitingPhase 3
- Alkermes Investigational Site, St Louis
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
RecruitingPhase 3
- Clinical Research Site, St Louis
Disorders of Excessive Somnolence trials in other cities
- Cincinnati, OH9 studies
- San Antonio, TX9 studies
- Atlanta, GA9 studies
- Miami, FL8 studies
- Charlotte, NC8 studies
- Austin, TX7 studies
- Sugar Land, TX7 studies
- Columbia, SC7 studies
- Orlando, FL7 studies
- Brandon, FL6 studies
- Los Angeles, CA5 studies
- Macon, GA5 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.